Skip to main content

SYSTEMATIC REVIEW article

Front. Aging Neurosci.

Sec. Alzheimer's Disease and Related Dementias

Volume 17 - 2025 | doi: 10.3389/fnagi.2025.1549134

Neural correlates of subjective cognitive decline in Alzheimer's disease: a systematic review of structural and functional brain changes for early diagnosis and intervention

Provisionally accepted
  • Bonino Pulejo Neurology Center (IRCCS), Messina, Italy

The final, formatted version of the article will be published soon.

    Background: Subjective Cognitive Decline (SCD) is increasingly recognized as a preclinical stage of Alzheimer's disease (AD), representing a critical window for early detection and intervention. Understanding the structural and functional neural changes in SCD can improve diagnosis, monitoring, and management of this early stage of disease. Methods: A systematic review was conducted using PubMed, Web of Science, and Scopus databases to identify studies examining neuroanatomical, neurofunctional, and neuroimaging findings in individuals with SCD. Inclusion criteria emphasized studies exploring SCD's potential as an early biomarker for AD progression. Results: A total of 2.283 studies were screened, with 17 meeting the inclusion criteria. Evidence indicates that SCD is associated with cortical thinning and reductions in gray matter volume (GMV), particularly in the hippocampus, entorhinal cortex, and medial temporal lobe. Functional imaging studies reveal disruptions in the default mode network (DMN), executive control networks (ECN), and sensorimotor networks (SMN), indicating both compensatory mechanisms and early dysfunction. Dynamic functional connectivity studies report reduced brain activity efficiency, while graph theory analyses show decreased network integration. Advanced neuroimaging techniques and machine learning (ML) approaches demonstrate significant promise in detecting subtle neural changes in SCD, with applications for early diagnosis and monitoring disease progression. Conclusion: SCD represents a heterogeneous condition characterized by mixed compensatory and degenerative neural changes, marking a critical early stage in the AD continuum. Combining structural and functional brain alterations with advanced neuroimaging and ML methodologies provides valuable biomarkers for early detection. Future longitudinal and multimodal studies are essential to standardize methodologies, account for individual variability, and develop personalized interventions aimed at mitigating progression to dementia.

    Keywords: Alzheimer's disease, Subjective cognitive decline, Neuroimaging, machine learning, functional connectivity, early diagnosis

    Received: 20 Dec 2024; Accepted: 07 Apr 2025.

    Copyright: © 2025 Marafioti, Culicetto, Latella, Marra, Quartarone and Lo Buono. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Laura Culicetto, Bonino Pulejo Neurology Center (IRCCS), Messina, Italy

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more